Evolent Health (EVH) Misses Q3 EPS by 24c, provides guidance

Evolent Health (NYSE: EVH) reported Q3 EPS of $0.04, $0.24 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $621.4 million versus the consensus estimate of $627.17 million.

GUIDANCE:

Evolent Health sees FY2024 revenue of $2.55-2.575 billion, versus the consensus of $2.577 billion.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• XORTX to voluntarily delist from TSX Venture Exchange